Industry3d ago
Industry
Insilico Moves AI Drug Discovery To Greenville
A $500 million valuation defines GNQ Insilico as it relocates its operations to Greenville. The firm leverages computational science and AI to identify treatments for cancer and metabolic diseases. This move expands the local biotech footprint. Practitioners should monitor how the company integrates its discovery pipeline into new regional research hubs.